WILL-BLEED (CABG Perioperative Bleeding) Calculator

Clinical calculation support · Verify results before clinical use

Preoperative risk assessment

Enter the patient's preoperative findings to calculate the published additive WILL-BLEED score for isolated CABG.

—Total score
01

Sex and hemoglobin

Preoperative anemia thresholds used in the published score: Hb <12 g/dL in women or <13 g/dL in men.

Anemia +3 · Female +2
02

Renal function

Use the preoperative estimated glomerular filtration rate.

eGFR <45: +3
03

Acute coronary syndrome

ACS diagnosis during the current admission.

Yes: +2
04

Recent P2Y12 inhibitor exposure

Select yes if a P2Y12 inhibitor classified as potent in the source definition was discontinued less than 5 days before surgery. Confirm drug-specific eligibility against the original publication/local protocol.

Yes: +2
05

Preoperative heparin / anticoagulant exposure

Use the source-defined exposure to LMWH, fondaparinux, or UFH in the preoperative period.

Yes: +1
06

Critical preoperative state

Select if any listed critical-state criterion is present. The criterion contributes once, regardless of the number of boxes selected.

Any criterion: +5
—WILL-BLEED
Published risk category
Complete all required fields
The score and risk group will appear here after calculation.
Clinical interpretation

This calculator implements the published additive score and its observed risk groups; it does not replace individualized perioperative assessment.

No individual probability is calculated because the original logistic-regression coefficients could not be independently verified from the accessible primary-source record. The validated published risk bands are reported instead.

About the WILL-BLEED score

WILL-BLEED was developed to stratify the risk of severe perioperative bleeding in patients undergoing isolated coronary artery bypass grafting (CABG). The original study derived the score in 2,494 patients and validated it in 1,250 patients from the E-CABG registry.

The primary outcome was E-CABG bleeding grade 2–3, defined in the report as transfusion of more than 4 units of red blood cells or reoperation for bleeding.

Score components

PredictorCriterionPoints
Preoperative anemiaHb <12 g/dL in women or <13 g/dL in men3
Female sexFemale2
Renal dysfunctioneGFR <45 mL/min/1.73 m²3
Recent antiplatelet exposureSource-defined potent antiplatelet drug discontinued <5 days pre-op2
Critical preoperative stateAny qualifying critical-state criterion5
Acute coronary syndromeACS during current admission2
Heparin exposureLMWH, fondaparinux, or UFH preoperatively1

Observed risk in the original study

ScoreRisk groupDerivation cohortValidation cohort
0–3Low2.9%3.4%
4–6Intermediate6.8%7.5%
>6High24.6%24.2%

These percentages are observed cohort event rates, not a separately calibrated patient-specific probability. Performance may differ across institutions, contemporary surgical practice, and patient populations.

References

Biancari F, Brascia D, Onorati F, et al.Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score. Thromb Haemost. 2017;117(3):445–456. DOI: 10.1160/TH16-09-0721. PMID: 27904903.
External validation of the WILL-BLEED Risk ScoreInstitutional external validation report available from the University of Oulu repository: Open full text (PDF).

Important scope limits

  • Intended for preoperative risk stratification in isolated CABG, not all cardiac surgery procedures.
  • Use the original publication to resolve operational definitions of critical preoperative state and antiplatelet exposure when uncertain.
  • Do not use the score alone to decide surgical timing, transfusion strategy, or antithrombotic management.
Clinical disclaimer: This educational calculator is intended to support, not replace, clinical judgment. Verify inputs and source definitions before use. The reported risk groups are based on observed rates in the original derivation and validation cohorts; calibration in the local population is not established by this tool.